Immunocore Holdings IMCR Cash Flow Statement (2019-2026)

NASDAQ IMCR
$36.13 -1.44 (-3.85%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Immunocore Holdings Quarterly Cash Flow Statement

Periods 21 quarters
Latest Jun 2026

Immunocore Holdings reported cash from operations of $15.93M and free cash flow of $15.14M for the quarter ended Jun 2026, down 38.7% year over year. This cash flow statement covers 21 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2019 Dec2020 Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-41.54M-53.10M-19.69M7.34M-29.56M-19.46M-17.62M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M-30.06M12.97M-0.81M
Share-based CompensationStock Comp.
6.01M12.68M11.76M9.34M7.18M8.06M8.26M8.75M8.20M7.19M9.54M10.00M6.56M8.67M9.49M10.03M9.84M8.34M6.30M9.40M
Cash from OperationsCash from Ops.
-22.02M9.54M7.08M10.54M0.04M10.09M-17.73M-4.59M23.47M21.13M-13.95M0.43M25.96M-4.46M-32.66M-13.78M15.93M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.41M0.40M0.40M0.44M0.43M0.43M0.49M0.56M0.55M0.57M0.57M0.67M0.63M0.61M
Change in Working Capital
Change in ReceivablesChange Receivables
-4.67M-5.98M-8.29M3.58M3.60M0.47M10.22M6.20M2.66M2.19M1.29M-0.84M4.18M5.99M-1.99M7.93M14.62M
Change in Account PayablesChange Payables
8.61M18.89M13.19M-3.02M5.98M-4.09M3.75M-2.32M4.48M-0.78M5.88M3.34M-6.93M-0.29M1.42M5.97M-4.80M
Change in Accured ExpensesChange Accured Exp.
4.58M7.30M11.23M15.98M19.17M26.86M26.70M-1.23M-10.94M33.73M15.13M-22.03M-8.30M27.00M
Other Working Capital ChangesOther WC Changes
-0.00M-0.10M-0.15M-0.14M-0.15M-0.15M
Investing Activities
Capital ExpendituresCapex
0.37M0.46M1.08M3.00M1.40M0.21M0.82M0.43M0.33M0.83M3.58M0.30M0.41M0.75M2.88M1.78M0.79M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.02M
Change in Acquisitions & DivestmentsChange Acquisitions
10.00M6.00M2.00M6.00M
Cash from Investing ActivitiesCash from Investing
-0.36M0.24M0.39M-3.00M-1.40M-0.21M-0.82M-0.43M-350.33M-0.83M-3.54M9.70M-30.41M5.25M-0.88M4.22M-0.79M
Financing Activities
Other financing activitiesOther financing
6.14M11.58M10.38M6.25M5.75M0.30M0.20M0.55M2.55M3.67M1.87M4.28M0.66M16.48M
Cash from Financing ActivitiesCash from Financing
-2.78M138.50M-1.40M6.14M11.58M10.38M6.25M396.01M-0.82M0.20M-51.51M2.55M3.67M1.87M4.28M0.66M16.48M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
6.34M1.77M0.85M0.87M
Additional items
Exchange Rate EffectFX Effect
-0.01M15.69M-23.25M2.23M3.39M-8.11M10.78M-0.80M-0.16M12.29M-13.03M8.43M11.87M7.82M-1.45M-6.13M0.62M
Change in Cash
-25.15M148.28M6.07M13.68M10.23M20.25M-12.30M391.00M-327.68M20.50M-69.00M12.69M-0.78M2.66M-29.25M-8.90M31.63M
Free Cash FlowFCF
-22.39M9.07M6.00M7.54M-1.35M9.88M-18.55M-5.02M23.14M20.30M-17.54M0.14M25.55M-5.20M-35.53M-15.56M15.14M
Net Cash FlowNCF
-25.15M148.28M6.07M13.68M10.23M20.25M-12.30M391.00M-327.68M20.50M-69.00M12.69M-0.78M2.66M-29.25M-8.90M31.63M